Publication & Citation Trends
Publications
0 total
Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group.
Cited by 222
Semantic Scholar
Central Nervous System (CNS) Involvement In Pediatric Relapsed Acute Myeloid Leukemia: Results and Lessons From Study Relapsed AML 2001/01
Cited by 3
Semantic Scholar
CLINICAL RELEVANCE OF CYTOGENETICS IN RELAPSED PEDIATRIC AML : RESULTS FROM THE INTERNATIONAL RANDOMISED PHASE III STUDY RELAPSED AML 2001/01
Cited by 0
Semantic Scholar
Addition of Liposomal Daunorubicin (DaunoXome®) to FLAG Significantly Improves Treatment Response in Pediatric Relapsed AML: Final Results From the International Randomised Phase III Study Relapsed AML 2001/01.
Cited by 7
Semantic Scholar
Prognostic Significance of Time to Relapse in Pediatric AML: Results from the International Randomised Phase III Study Relapsed AML 2001/01
Cited by 2
Semantic Scholar
Long-Term Continuing Second Complete Remission (CCR2) despite Allogeneic Stem Cell Transplantation in CR1: Results from the International Randomised Phase III Study Pediatric Relapsed AML 2001/01
Cited by 0
Semantic Scholar
Prognostic Significance of Early Treatment Response in Pediatric Relapsed Acute Myeloid Leukemia: Results from the International Study Relapsed AML 2001/01. OA
Cited by 2
Semantic Scholar
Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): Single‐agent therapeutic window study in relapsed AML
Cited by 2
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(11)
Acute Lymphoblastic Leukemia research
(5)
Hematopoietic Stem Cell Transplantation
(4)
Histone Deacetylase Inhibitors Research
(3)
Protein Degradation and Inhibitors
(2)
Affiliations
Instituto Argentino de Diagnóstico y Tratamiento
Hospital de Niños Superiora Sor María Ludovica